european medicines agency glp-1 vision loss recommendation november 2025 Possible Link Between RA Medications & Eye Health Meeting highlights from the Committee

Mounjaro's Suitability for GIP & GLP-1 Action Who is Suitable for Mounjaro: Mounjaro are suitable for selected adults only who are overweight or obese, especially those with weight-related health concerns or has difficulty in managing appetite, cravings, or weight regain

If you are approaching 1.0 mg or above and still using 2.5mg/mL vials, ask your provider about switching to 5mg/mL vials for more practical measurements and better cost efficiency

GLP1 receptors are also found in brain regions involved in appetite, reward, motivation, stress response, and metabolic regulation

Clinical Evidence Supporting GLP-1 Therapy Studies show that patients on GLP-1 therapy can achieve significant weight reduction over several months, particularly when paired with a supervised weight management plan

Clients who lose weight while protecting muscle and skin, supporting their metabolism, and staying accountable through weekly check-ins are significantly more likely to maintain their results

[DOI] [PMC free article] [PubMed] [Google Scholar] 963.Ormazabal V., Nair S., Elfeky O., Aguayo C., Salomon C., Zuniga F.A